End-of-day quote
Shanghai S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
2.05
CNY
|
+4.59%
|
|
-3.76%
|
-22.05%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
15,502
|
12,490
|
8,189
|
18,764
|
14,883
|
9,364
|
Enterprise Value (EV)
1 |
15,174
|
12,518
|
11,927
|
21,200
|
19,339
|
10,937
|
P/E ratio
|
20.2
x
|
13.8
x
|
15.7
x
|
22.9
x
|
19.9
x
|
-17.3
x
|
Yield
|
1.5%
|
2.19%
|
1.9%
|
-
|
0.55%
|
-
|
Capitalization / Revenue
|
0.89
x
|
1.01
x
|
0.63
x
|
1.51
x
|
1.33
x
|
1.07
x
|
EV / Revenue
|
0.87
x
|
1.01
x
|
0.92
x
|
1.7
x
|
1.73
x
|
1.25
x
|
EV / EBITDA
|
6
x
|
7.44
x
|
6.79
x
|
12.3
x
|
12.8
x
|
17.2
x
|
EV / FCF
|
3.34
x
|
-3.93
x
|
-8.36
x
|
-12.7
x
|
10.5
x
|
-15.4
x
|
FCF Yield
|
29.9%
|
-25.4%
|
-12%
|
-7.86%
|
9.48%
|
-6.48%
|
Price to Book
|
1.05
x
|
0.81
x
|
0.52
x
|
1.15
x
|
0.88
x
|
0.57
x
|
Nbr of stocks (in thousands)
|
3,560,626
|
3,560,626
|
3,560,626
|
3,560,622
|
3,560,622
|
3,560,622
|
Reference price
2 |
4.354
|
3.508
|
2.300
|
5.270
|
4.180
|
2.630
|
Announcement Date
|
4/16/19
|
4/7/20
|
4/16/21
|
4/29/22
|
4/28/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
17,371
|
12,367
|
12,915
|
12,439
|
11,178
|
8,761
|
EBITDA
1 |
2,531
|
1,683
|
1,756
|
1,727
|
1,515
|
636.2
|
EBIT
1 |
1,925
|
1,090
|
1,010
|
964.7
|
771
|
-162.5
|
Operating Margin
|
11.08%
|
8.82%
|
7.82%
|
7.76%
|
6.9%
|
-1.85%
|
Earnings before Tax (EBT)
1 |
1,284
|
1,261
|
734.2
|
882.5
|
1,003
|
-619.8
|
Net income
1 |
770.7
|
900
|
518.4
|
801.7
|
730.8
|
-541.8
|
Net margin
|
4.44%
|
7.28%
|
4.01%
|
6.44%
|
6.54%
|
-6.18%
|
EPS
2 |
0.2154
|
0.2538
|
0.1462
|
0.2300
|
0.2100
|
-0.1522
|
Free Cash Flow
1 |
4,541
|
-3,184
|
-1,427
|
-1,665
|
1,834
|
-708.8
|
FCF margin
|
26.14%
|
-25.74%
|
-11.05%
|
-13.39%
|
16.41%
|
-8.09%
|
FCF Conversion (EBITDA)
|
179.4%
|
-
|
-
|
-
|
121.09%
|
-
|
FCF Conversion (Net income)
|
589.14%
|
-
|
-
|
-
|
250.94%
|
-
|
Dividend per Share
2 |
0.0654
|
0.0769
|
0.0438
|
-
|
0.0230
|
-
|
Announcement Date
|
4/16/19
|
4/7/20
|
4/16/21
|
4/29/22
|
4/28/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
28.3
|
3,738
|
2,436
|
4,456
|
1,572
|
Net Cash position
1 |
328
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.0168
x
|
2.128
x
|
1.41
x
|
2.942
x
|
2.472
x
|
Free Cash Flow
1 |
4,541
|
-3,184
|
-1,427
|
-1,665
|
1,834
|
-709
|
ROE (net income / shareholders' equity)
|
6.33%
|
6.15%
|
3.38%
|
4.38%
|
4.71%
|
-3.05%
|
ROA (Net income/ Total Assets)
|
3.28%
|
1.91%
|
1.72%
|
1.71%
|
1.39%
|
-0.31%
|
Assets
1 |
23,528
|
47,000
|
30,159
|
46,880
|
52,452
|
177,181
|
Book Value Per Share
2 |
4.160
|
4.320
|
4.400
|
4.590
|
4.740
|
4.610
|
Cash Flow per Share
2 |
2.920
|
2.860
|
2.360
|
1.840
|
1.230
|
1.100
|
Capex
1 |
848
|
603
|
1,887
|
733
|
413
|
976
|
Capex / Sales
|
4.88%
|
4.88%
|
14.61%
|
5.89%
|
3.7%
|
11.14%
|
Announcement Date
|
4/16/19
|
4/7/20
|
4/16/21
|
4/29/22
|
4/28/23
|
4/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -22.05% | 1.01B | | +3.01% | 101B | | +1.20% | 65.99B | | +44.29% | 41.98B | | +15.99% | 38.65B | | +3.89% | 32.16B | | +6.82% | 19.21B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|